STAT+: Merck shares fall as sales of HPV vaccine drop in China
Shares of Merck fell 9% Tuesday after the company reported that in the second quarter,…
Author: STAT
CDC will offer seasonal flu shots to farmworkers to lower bird flu risk
The Centers for Disease Control and Prevention announced Tuesday that it is funding a $5…
STAT+: Picking apart health care lobbying, from Grindr to Lipton Tea
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Testing GLP-1s in Alzheimer’s, and is Medicare a good negotiator?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about the U.K. nixing coverage for a cancer drug, sharing bird flu vaccine data, and more
Top of the morning to you, and a fine one it is, despite the gray…
STAT+: Older GLP-1 drug may help protect brains of Alzheimer’s patients, early study suggests
A new study suggests that an older GLP-1 drug may help protect the brains of…
Opinion: How artificial intelligence can bolster Europe’s competitive edge in biopharma
In a year marked by European Parliament elections and setting of the European Union’s priorities…
STAT+: Health care’s ‘Pepsi challenge’: Doctors’ offices are testing AI tools in head-to-head pilots
The “Pepsi challenge” of health care, as one health system executive put it, is on….
There’s more data for trans people with HIV than any other disease — but it’s still flawed
Transgender people are at higher-than-average risk of contracting HIV. And yet, when epidemiologist Diana Tordoff…
STAT+: How to tell if Biden drove a hard bargain on drug prices
WASHINGTON — The deadline for announcing how much Medicare lowered drug prices in the first…
STAT+: Dental AI startup raises $30 million, including from Mark Zuckerberg’s dad
As the AI race in dentistry grows more heated, a startup called Perceptive is aiming…
STAT+: Parasite engineered to treat brain development disorder in mice shows potential in study
The human body works hard to prevent outside substances from entering the brain — which…
Dating app Grindr hires Tom Daschle’s firm to lobby on HIV prevention, IVF
WASHINGTON — LGBTQ+ dating app Grindr is tapping into the Washington lobbying world amid legislative…
STAT+: For-profit hospitals are getting a boost from a flood of patients
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Morning Rounds: Would a bird flu vaccine for cows work?
Want to stay on top of health news? Sign up to get our Morning Rounds…
Blood tests for Alzheimer’s diagnosis were 91% accurate in new study
New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday –…
New cardiovascular risk model could greatly decrease use of statins and increase heart attacks, study warns
If up to half of Americans no longer qualify for a statin or a blood…
STAT+: In a big step for liquid biopsy, FDA approves a blood test for colorectal cancer
The Food and Drug Administration on Monday approved a blood test intended to detect colon…
The biotech news you need from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: Pharmalittle: We’re reading about Sarepta’s demand to censor a critical video, Roche fast-tracking an obesity pill, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Could cow vaccines help halt the spread of bird flu in U.S. herds? Experts are divided
With the number of U.S. dairy herds infected with H5N1 bird flu rising almost daily,…
.jpg)
Bird flu snapshot: Upstart manufacturers in low- and middle-income countries to start early vaccine work
Bird flu snapshot: This is the latest installment in a series of regular updates on…
STAT+: Sarepta demanded Duchenne patient advocacy group censor video critical of the company
Sarepta Therapeutics demanded a prominent patient advocacy organization censor a video that contained pointed criticism…
STAT+: Disruptions loom for telehealth providers and patients as Congress inches closer to deadline
Around November, Kivo Health, a telehealth provider of pulmonary rehabilitation services, will need to start…
Opinion: Mark Cuban’s company won’t fix drug costs, but it can still help rectify America’s drug shortages
Americans are facing at least two prescription drug crises simultaneously. One is the outrageously high…
Opinion: Leveraging scientific excellence to improve investment decisions
To invest is to embrace an unpredictable future, filled with risks and uncertainties. To navigate…
Opinion: Survey: Neurologists split on prescribing new Alzheimer’s treatments
As more than 7,500 clinicians and researchers converge in Philadelphia for the Alzheimer’s Association International…
Sonya Massey’s death: How to prevent more killings of defenseless Black women
On July 6, 2024, Sonya Massey, 36, called 911 to report a potential home intruder…
Morning Rounds: Three new bird flu cases in humans brings total to 13 in U.S.
Want to stay on top of health news? Sign up to get our Morning Rounds…
STAT+: Pharmalittle: We’re reading about a thumbs down for an Alzheimer’s drug, Pfizer gene therapy struggles, and more
And so, another working week will soon draw to a close. Not a moment too…
The worst for Dexcom may not be over
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: European regulators say Alzheimer’s therapy Leqembi should be rejected
LONDON — European regulators on Friday said that an Alzheimer’s therapy from Eisai and Biogen…
STAT+: How Pfizer’s grand gene therapy ambitions crumbled
A decade ago, Pfizer began investing heavily in gene therapy, bringing in experimental treatments for…
How Kamala Harris’ views on health care were shaped by her mother, cancer researcher Shyamala Gopalan
As Vice President Kamala Harris emerges as the likely Democratic candidate in the U.S. presidential…
Opinion: Medtech compliance — not regulation — is stifling innovation
“Regulation is stifling innovation” seems to be a prevailing opinion among medtech leaders who believe…
Opinion: Without federal oversight, nursing homes will put profit ahead of care
About 5% of Americans require skilled care at some point as they age. The horrific…
Listen: UnitedHealth’s doctor empire, an FDA departure, and Viking’s obesity moves
What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And…
STAT+: Powerful Senate committee demands testimony from CEO of bankrupt Steward hospital chain
Federal lawmakers investigating the Steward Health Care bankruptcy moved on Thursday to compel testimony from…
STAT+: Do medical errors creep up at hospitals when interns arrive? Yes, but the ‘July effect’ is minimal.
For Dr. Jeremy Faust, July 1 is like New Year’s Day. That’s when thousands of…
Breast cancer study reveals a paradox of mastectomy
Breast cancer surgeons have tended not to push patients towards bilateral mastectomy, since data have…
STAT+: The state pharma’s targeting this election cycle
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Roche CEO explains the company’s weight loss drug strategy in crowded market
LONDON — In the booming field of weight loss drugs, Roche has been riding high…
A neurological disorder stole her voice. Jennifer Wexton takes it back on the House floor
When Jennifer Wexton rises Thursday to speak on the House floor, something she has done…
Six questions about Medicare’s proposed plan to cover digital therapeutics
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: A preview of Neurocrine’s muscarinic drug readout
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
A potential rival for Wegovy and Zepbound enters the fray
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a Viking obesity drug, Bausch Health’s bankruptcy denial, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Federal regulation of health data and AI expected to get a boost after HHS revamp
A little-known office within the Department of Health and Human Services is getting a shot…
STAT+: How UnitedHealth harnesses its physician empire to squeeze profits out of patients
UnitedHealth Group started out as a small, Minnesota health insurance company and has since morphed…
Opinion: Sponsored genetic testing programs are under fire, further complicating life for people with rare diseases
It takes years for most people with a rare disease to learn what is ailing…